Precision Optics Corporation Inc

Precision Optics Corporation Inc(POCI)股票分析

$4.887

-0.062 (-1.27%)收盤時

Loading chart…
最高
4.930
開盤
4.825
成交量加權均價
4.88
成交量
9.87K
市值
35.15M
最低
4.825
成交金額
48.18K
企業價值/稅息折舊攤銷前利潤(TTM)
-319.48

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications.

AI 分析 of Precision Optics Corporation Inc (POCI)

買進

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

估值指標

Precision Optics Corporation Inc(POCI)目前預期本益比為 0.00,5 年平均預期本益比為 0.00。

預期本益比

嚴重低估
5 年均值 P/E
0.00
目前P/E
0.00
高估
0.00
低估
0.00

預期 EV/EBITDA

合理
5 年均值 EV/EBITDA
307.03
目前EV/EBITDA
-319.48
高估
1354.40
低估
-740.33

預期股價營收比

嚴重高估
5 年均值 P/S
0.17
目前P/S
1.53
高估
0.64
低估
-0.31

Alphio AI 對 POCI 的價格情境

情境價格取自當年最後一個月度預測區間。機率為固定的模型權重(25 / 50 / 25),不構成保證。

樂

樂觀

樂觀 · 25%POCI

$4.83

情境價格

基

基準

基準 · 50%POCI

$4.56

情境價格

悲

悲觀

悲觀 · 25%POCI

$3.87

情境價格

事件時間軸

2026-11-05 (ET)

10:30:00

Precision Optics Receives $2M Aerospace Order

2026-09-17 (ET)

09:30:00

Precision Optics Secures $50,000 Satellite Development Order

2026-09-10 (ET)

09:30:00

Precision Optics Receives $1.3M Follow-On Orders

2026-03-27 (ET)

07:50:00

Lucid Capital Offering Priced Below Last Closing Price of $4.21

2026-03-26 (ET)

16:10:00

Precision Optics Corporation Launches Underwritten Public Offering

資訊

POCI 常見問題 —— 由 Alphio AI 解答

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易